6-month HIV PrEP makes coverage gains with insurers - The Hill
Health
The FDA approved?Yeztugo, a 6-month biannual HIV?PrEP?injection, in June of last year. But health insurers were openly hesitant about covering the drug?due?to its annual cost of?nearly $30,000.? By ? [+1543 chars]

Leave A Comment

Comments are moderated and may take time to appear.

Comments

No comments yet. Be the first to comment!

Popular Categories

Stay Connected

Loading...